Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 60530 | 151.71 |
09:34 ET | 8690 | 151.05 |
09:36 ET | 19860 | 151.835 |
09:38 ET | 11381 | 152.07 |
09:39 ET | 14305 | 152.515 |
09:41 ET | 7612 | 151.5301 |
09:43 ET | 5507 | 152.48 |
09:45 ET | 10395 | 151.8 |
09:48 ET | 4290 | 151.58 |
09:50 ET | 7483 | 151.82 |
09:52 ET | 11169 | 152.195 |
09:54 ET | 5426 | 151.59 |
09:56 ET | 8373 | 151.16 |
09:57 ET | 12580 | 151.735 |
09:59 ET | 5155 | 151.64 |
10:01 ET | 8325 | 151.71 |
10:03 ET | 7744 | 152.14 |
10:06 ET | 6196 | 152.56 |
10:08 ET | 21677 | 150.865 |
10:10 ET | 24681 | 150.27 |
10:12 ET | 13332 | 151.34 |
10:14 ET | 11328 | 150.84 |
10:15 ET | 19320 | 151.3 |
10:17 ET | 14707 | 151 |
10:19 ET | 3815 | 150.9931 |
10:21 ET | 2007 | 150.87 |
10:24 ET | 13886 | 150.13 |
10:26 ET | 27070 | 150.07 |
10:28 ET | 8405 | 150.67 |
10:30 ET | 5193 | 150.985 |
10:32 ET | 8703 | 150.975 |
10:33 ET | 3528 | 150.885 |
10:35 ET | 4673 | 150.94 |
10:37 ET | 3838 | 150.93 |
10:39 ET | 2851 | 151.4 |
10:42 ET | 11028 | 151.42 |
10:44 ET | 4840 | 151.472 |
10:46 ET | 7541 | 151.695 |
10:48 ET | 3887 | 151.9 |
10:50 ET | 7847 | 152 |
10:51 ET | 5248 | 151.93 |
10:53 ET | 2973 | 152.305 |
10:55 ET | 9872 | 151.67 |
10:57 ET | 4790 | 151.52 |
11:00 ET | 2310 | 151.41 |
11:02 ET | 6438 | 151.28 |
11:04 ET | 4541 | 151.22 |
11:06 ET | 6063 | 151.31 |
11:08 ET | 7784 | 150.8925 |
11:09 ET | 20428 | 151.435 |
11:11 ET | 5629 | 151.435 |
11:13 ET | 14516 | 151.69 |
11:15 ET | 7747 | 151.52 |
11:18 ET | 2228 | 151.67 |
11:20 ET | 2891 | 151.715 |
11:22 ET | 1749 | 151.79 |
11:24 ET | 15754 | 152.7781 |
11:26 ET | 8453 | 152.95 |
11:27 ET | 13376 | 152.906 |
11:29 ET | 9067 | 152.84 |
11:31 ET | 5714 | 152.82 |
11:33 ET | 7759 | 152.76 |
11:36 ET | 2771 | 152.85 |
11:38 ET | 3300 | 152.42 |
11:40 ET | 6120 | 153.02 |
11:42 ET | 7931 | 152.8967 |
11:44 ET | 9635 | 152.94 |
11:45 ET | 16953 | 153.46 |
11:47 ET | 8646 | 153.413 |
11:49 ET | 1011 | 153.42 |
11:51 ET | 7810 | 153.49 |
11:54 ET | 2681 | 153.19 |
11:56 ET | 3223 | 152.79 |
11:58 ET | 4685 | 153.1231 |
12:00 ET | 1580 | 152.91 |
12:02 ET | 3946 | 152.86 |
12:03 ET | 1744 | 152.96 |
12:05 ET | 1910 | 152.88 |
12:07 ET | 350 | 152.895 |
12:09 ET | 1522 | 153.07 |
12:12 ET | 2389 | 152.68 |
12:14 ET | 2910 | 152.8 |
12:16 ET | 1655 | 152.8909 |
12:18 ET | 920 | 152.805 |
12:20 ET | 1200 | 152.715 |
12:21 ET | 3662 | 152.615 |
12:23 ET | 2160 | 152.6 |
12:25 ET | 3229 | 152.73 |
12:27 ET | 1780 | 152.81 |
12:30 ET | 1780 | 152.735 |
12:32 ET | 6220 | 152.7671 |
12:34 ET | 2967 | 152.8 |
12:36 ET | 2586 | 152.62 |
12:38 ET | 4313 | 152.28 |
12:39 ET | 2171 | 152.47 |
12:41 ET | 2304 | 152.484 |
12:43 ET | 4234 | 152.355 |
12:45 ET | 2013 | 152.47 |
12:48 ET | 5776 | 152.37 |
12:50 ET | 2441 | 152.435 |
12:52 ET | 2714 | 152.5578 |
12:54 ET | 4008 | 152.69 |
12:56 ET | 1200 | 152.77 |
12:57 ET | 1626 | 152.975 |
12:59 ET | 1950 | 152.94 |
01:01 ET | 7173 | 152.8 |
01:03 ET | 1500 | 152.8 |
01:06 ET | 1580 | 152.96 |
01:08 ET | 2631 | 152.99 |
01:10 ET | 3370 | 152.91 |
01:12 ET | 3055 | 152.7631 |
01:14 ET | 1263 | 152.8725 |
01:15 ET | 1903 | 152.79 |
01:17 ET | 5535 | 152.92 |
01:19 ET | 2430 | 152.735 |
01:21 ET | 1847 | 153.02 |
01:24 ET | 3187 | 153.19 |
01:26 ET | 3180 | 152.985 |
01:28 ET | 2633 | 152.67 |
01:30 ET | 5012 | 152.415 |
01:32 ET | 6820 | 152.23 |
01:33 ET | 1550 | 152.29 |
01:35 ET | 3421 | 152.26 |
01:37 ET | 5345 | 152.07 |
01:39 ET | 10307 | 151.69 |
01:42 ET | 3561 | 151.5 |
01:44 ET | 2416 | 151.52 |
01:46 ET | 883 | 151.53 |
01:48 ET | 5103 | 151.22 |
01:50 ET | 3172 | 151.24 |
01:51 ET | 6456 | 151.06 |
01:53 ET | 3292 | 150.89 |
01:55 ET | 5030 | 150.9236 |
01:57 ET | 6089 | 150.83 |
02:00 ET | 4847 | 150.88 |
02:02 ET | 29245 | 150.11 |
02:04 ET | 6685 | 150.19 |
02:06 ET | 7179 | 149.6 |
02:08 ET | 5469 | 149.7489 |
02:09 ET | 6882 | 149.69 |
02:11 ET | 8034 | 149.56 |
02:13 ET | 2029 | 149.405 |
02:15 ET | 6356 | 149.4 |
02:18 ET | 10738 | 149.13 |
02:20 ET | 7121 | 149.435 |
02:22 ET | 10529 | 150.01 |
02:24 ET | 14103 | 150 |
02:26 ET | 4146 | 149.87 |
02:27 ET | 7032 | 150.01 |
02:29 ET | 6254 | 149.835 |
02:31 ET | 15314 | 149.69 |
02:33 ET | 5826 | 149.82 |
02:36 ET | 2546 | 149.8 |
02:38 ET | 5592 | 149.765 |
02:40 ET | 5335 | 149.56 |
02:42 ET | 7318 | 149.465 |
02:44 ET | 7477 | 149.525 |
02:45 ET | 7930 | 149.825 |
02:47 ET | 5741 | 150.09 |
02:49 ET | 5199 | 149.96 |
02:51 ET | 7091 | 150.09 |
02:54 ET | 3691 | 150.1621 |
02:56 ET | 5000 | 150.13 |
02:58 ET | 3365 | 149.9 |
03:00 ET | 6390 | 149.6 |
03:02 ET | 3234 | 149.3 |
03:03 ET | 3151 | 149.6 |
03:05 ET | 3866 | 149.57 |
03:07 ET | 1760 | 149.66 |
03:09 ET | 6011 | 149.625 |
03:12 ET | 4309 | 149.73 |
03:14 ET | 5685 | 149.66 |
03:16 ET | 3021 | 149.94 |
03:18 ET | 6869 | 150 |
03:20 ET | 8665 | 149.68 |
03:21 ET | 5785 | 149.645 |
03:23 ET | 9683 | 149.735 |
03:25 ET | 2803 | 149.97 |
03:27 ET | 3826 | 150.2049 |
03:30 ET | 2891 | 150.34 |
03:32 ET | 14089 | 150.84 |
03:34 ET | 8536 | 151.3 |
03:36 ET | 13073 | 151.5 |
03:38 ET | 11123 | 151.62 |
03:39 ET | 10874 | 151.32 |
03:41 ET | 10988 | 151.09 |
03:43 ET | 14973 | 150.85 |
03:45 ET | 10581 | 150.84 |
03:48 ET | 9115 | 150.79 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 54.6B | -9.6x | --- |
ICON PLC | 26.9B | 38.8x | +4.68% |
Biogen Inc | 32.8B | 28.1x | -18.14% |
Biontech SE | 23.9B | 194.6x | --- |
Grifols SA | 6.2B | 74.2x | --- |
Charles River Laboratories International Inc | 10.7B | 25.2x | +15.57% |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $54.6B |
---|---|
Revenue (TTM) | $5.2B |
Shares Outstanding | 383.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.54 |
EPS | $-15.66 |
Book Value | $36.27 |
P/E Ratio | -9.6x |
Price/Sales (TTM) | 10.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -99.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.